Carter Worth, Worth Charting, talks technicals on Morgan Stanley and Novo Nordisk.
Source link
Trending
- 'Whole host of other factors' outside of tariffs driving volatility, says CME Group's Terry Duffy
- GE Vernova CEO describes huge electricity demand in the U.S.
- Korea GDP, SK Hynix, U.S.-China trade
- What’s likely to move the market
- Pres.Trump: Fed Chair Powell making a mistake not lowering interest rates
- GM to increase production at Ohio transmission facility
- Trump Team Races to Form Trade Deals After Tariffs Sow Global Chaos
- Final Trade: DAL, WNS, TXN, NKE
Chart Master: Sell Morgan Stanley, buy Novo Nordisk?
